BRB-N
|
MS patients
|
Healthy controls
|
---|
|
Raw scores
|
Standardized scores
|
Raw scores
|
Standardized scores
|
---|
SRT-LTS
|
40.85 ± 17.18 (0–72)
|
−0.30 ± 1.10
|
50.75 ± 11.68 (14–70)
|
0.34 ± 0.75
|
SRT-CLTR
|
31.43 ± 18.68 (0–72)
|
−0.32 ± 1.04
|
43.60 ± 14.58 (2–70)
|
0.36 ± 0.81
|
SRT-D
|
7.99 ± 3.07 (0–12)
|
−0.30 ± 1.13
|
9.71 ± 1.87 (5–12)
|
0.34 ± 0.69
|
SPART
|
18.91 ± 5.51 (5–30)
|
−0.37 ± 1.00
|
23.26 ± 4.55 (10–30)
|
0.42 ± 0.83
|
SPART-D
|
6.85 ± 2.34 (0–10)
|
−0.30 ± 1.05
|
8.26 ± 1.85 (1–12)
|
0.34 ± 0.83
|
SDMT
|
46.20 ± 15.30 (4–84)
|
−0.52 ± 0.94
|
64.30 ± 11.24 (37–91)
|
0.59 ± 0.69
|
PASAT3
|
40.83 ± 15.44 (0–60)
|
−0.40 ± 1.14
|
52.45 ± 7.26 (24–60)
|
0.45 ± 0.54
|
PASAT2
|
30.18 ± 14.02 (0–60)
|
−0.41 ± 1.06
|
41.55 ± 8.94 (18–60)
|
0.46 ± 0.68
|
WLG
|
21.95 ± 7.21 (2–37)
|
−0.40 ± 1.02
|
27.99 ± 5.29 (12–40)
|
0.45 ± 0.75
|
- For each test, data are expressed as mean ± standard deviation scores (ranges). MS patient scores were significantly different from healthy control scores for all tests (p < 0.0001).